Dr. Ze Zhang graduated from the University of Southern California with a BA in Biological Sciences and Business Administration in 2008. She received her medical degree from Yale School of Medicine in 2013. Dr. Zhang completed her internship at Tulane University School of Medicine, Department of Internal Medicine and her residency in the Ophthalmology Department in 2017. She completed a Fellowship in Glaucoma at the University of Iowa School of Medicine in 2018.
Dr. Zhang has been published in multiple journals, including the British Journal of Ophthalmology, has collaborated in research related to glaucoma at both the University of Iowa Department of Ophthalmology and the Tulane Department of Ophthalmology and has received multiple honors. She is a member of the American Glaucoma Society, the American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgery and the Association for Research in Vision and Ophthalmology.
Dr. Zhang is fluent in English, Mandarin, Norwegian, Danish and Swedish
An Answer for Millions with Dry Eye
There are nearly 30 million people in the United States and over 300 million worldwide who have been diagnosed with dry eye. Most have learned to live with eye discomfort and have become dependent on drops or other treatment methods that only offer temporary relief. This has been due to a lack of understanding that the root cause of most dry eye is now known to be a chronic and progressive condition, Meibomian Gland Dysfunction or MGD. MGD affects 86% of all those with Dry Eye and it’s treatable.
Treating MGD with LipiFlow®
While there are multiple choices available for treating MGD, LipiFlow is the only FDA-cleared device for removing gland blockages and restoring gland function. Through advances in the application of Vectored Thermal Pulsation (VTPTM) technology, the LipiFlow treatment utilizes a patented algorithm of heat applied to the inner eyelids and massage to remove the obstructions in your meibomian glands.